ACVR2A and malignant colon neoplasm: This is the first report describing ACVR2 loss in MSS colon cancers and ACVR2 promoter hypermethylation as a mechanism, and contrasts with the mechanisms of ACVR2 loss in the MSI colon cancer cells [12].